These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29240593)

  • 41. Evidence-based management of keloids and hypertrophic scars in dermatology.
    Kim EY; Hussain A; Khachemoune A
    Arch Dermatol Res; 2023 Aug; 315(6):1487-1495. PubMed ID: 36504113
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Comparative study of collagen in hypertrophic and keloid cicatrix].
    Podobed OV; Prozorovskiĭ NN; Kozlov EA; Tsvetkova TA; Vozdvizhenskiĭ SI; Del'vig AA
    Vopr Med Khim; 1996; 42(3):240-5. PubMed ID: 9139458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The morphologic characteristics of scar tissues and the new clinicomorphologic classification of human skin scars].
    Shekhter AB; Guller AE
    Arkh Patol; 2008; 70(1):6-13. PubMed ID: 18368800
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Variations of lipid peroxidation products and copper, zinc-superoxide dismutase in pathological scars].
    Li W; Cen Y; Wang H; Chen W; Liu D
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):838-41. PubMed ID: 18681286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management.
    Wolfram D; Tzankov A; Pülzl P; Piza-Katzer H
    Dermatol Surg; 2009 Feb; 35(2):171-81. PubMed ID: 19215252
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Scar management: keloid, hypertrophic, atrophic, and acne scars.
    Tsao SS; Dover JS; Arndt KA; Kaminer MS
    Semin Cutan Med Surg; 2002 Mar; 21(1):46-75. PubMed ID: 11911537
    [No Abstract]   [Full Text] [Related]  

  • 47. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures.
    España A; Solano T; Quintanilla E
    Dermatol Surg; 2001 Jan; 27(1):23-7. PubMed ID: 11231236
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Therapy for pathologic scars (hypertrophic scars and keloids)].
    Koller J; Sebastian G
    J Dtsch Dermatol Ges; 2004 Apr; 2(4):308-12. PubMed ID: 16285329
    [No Abstract]   [Full Text] [Related]  

  • 49. Oxygen consumption of keloids and hypertrophic scars.
    Ichioka S; Ando T; Shibata M; Sekiya N; Nakatsuka T
    Ann Plast Surg; 2008 Feb; 60(2):194-7. PubMed ID: 18216515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
    Fang F; Huang RL; Zheng Y; Liu M; Huo R
    J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Are keloid and hypertrophic scar different forms of the same disorder? A fibroproliferative skin disorder hypothesis based on keloid findings.
    Huang C; Akaishi S; Hyakusoku H; Ogawa R
    Int Wound J; 2014 Oct; 11(5):517-22. PubMed ID: 23173565
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Heterogeneity of human fibroblasts isolated from hypertrophic scar.
    Ţuţuianu R; Roşca AM; Florea G; Prună V; Iacomi DM; Rădulescu LA; Neagu TP; Lascăr I; Titorencu ID
    Rom J Morphol Embryol; 2019; 60(3):793-802. PubMed ID: 31912089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.
    Tanriverdi-Akhisaroglu S; Menderes A; Oktay G
    Cell Biochem Funct; 2009 Mar; 27(2):81-7. PubMed ID: 19165813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are there differences between the performances of keloids and hypertrophic scars when applying non-surgical treatments?
    Che K; Lyu Q; Ma G
    J Dermatolog Treat; 2022 Feb; 33(1):589. PubMed ID: 32063076
    [No Abstract]   [Full Text] [Related]  

  • 55. [Replication of pathological scar in nude mice].
    Jin PS; Cen Y; Liu XX; Chen JJ; Xu XW; Liu Y; Li JJ; Wang Y
    Zhonghua Shao Shang Za Zhi; 2007 Apr; 23(2):126-9. PubMed ID: 17649888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Keloid or hypertrophic scar: the controversy: review of the literature.
    Atiyeh BS; Costagliola M; Hayek SN
    Ann Plast Surg; 2005 Jun; 54(6):676-80. PubMed ID: 15900161
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars.
    Teofoli P; Barduagni S; Ribuffo M; Campanella A; De Pita' O; Puddu P
    J Dermatol Sci; 1999 Dec; 22(1):31-7. PubMed ID: 10651227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alterations in fibroblast alpha1beta1 integrin collagen receptor expression in keloids and hypertrophic scars.
    Szulgit G; Rudolph R; Wandel A; Tenenhaus M; Panos R; Gardner H
    J Invest Dermatol; 2002 Mar; 118(3):409-15. PubMed ID: 11874478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Losartan ointment relieves hypertrophic scars and keloid: A pilot study.
    Hedayatyanfard K; Ziai SA; Niazi F; Habibi I; Habibi B; Moravvej H
    Wound Repair Regen; 2018 Jul; 26(4):340-343. PubMed ID: 30099811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Role of Hippo Signaling Pathway and ILK in the Pathophysiology of Human Hypertrophic Scars and Keloids: An Immunohistochemical Investigation.
    Petrou IG; Nikou S; Madduri S; Nifora M; Bravou V; Kalbermatten DF
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.